Influence of the combined lipid-lowering therapy on immuninflammatory reactions and endothelial function in patients with rheumatoid arthritis and ischemic heart disease - Статья
Optimizing lipid-lowering therapy and achieving it in three ways: increasing the dosage of statins. The pathogenesis of immune inflammatory reactions and endothelial dysfunction ischemic heart disease in combination with systemic inflammatory diseases.